Small molecules in stem cell research

Current Pharmaceutical Biotechnology

Volumn 14, Issue 1, 2013, Pages 36-45

  Schmöle, Anne Caroline ^a   Hübner, Rayk ^a   Beller, Matthias ^b   Rolfs, Arndt ^a   Frech, Moritz J ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b LEIBNIZ INSTITUT FÜR KATALYSE E V AN DER UNIVERSITÄT ROSTOCK   (Germany)

Author keywords

Embryonic stem cells; Induced pluripotent stem cells; Small molecules

Indexed keywords

1, 4 DIHYDRO 2, 6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL) PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3, 4 DIFLUOROBENZAMIDE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL] PROPIONIC ACID; 3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; 4 (1 AMINOETHYL) N (4 PYRIDYL) CYCLOHEXANECARBOXAMIDE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 [4 (1, 3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL] BENZAMIDE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ASCORBIC ACID; BAYK8644; BETA CATENIN; BISINDOLYLMALEIMIDE; BONE MORPHOGENETIC PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; ISOXAZOLE; JANUS KINASE INHIBITOR; KENPAULLONE; LEUKEMIA INHIBITORY FACTOR; METABOTROPIC RECEPTOR 5; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1, 4 DIAZEPIN 1 YL) 6, 7 DIMETHOXY 4 QUINAZOLINAMINE; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE; N (2, 3 DIHYDROXYPROPOXY) 3, 4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO) BENZAMIDE; OCTAMER TRANSCRIPTION FACTOR 4; PHENAZOPYRIDINE; PHOSPHATIDYLINOSITOL 3 KINASE; PINACIDIL; REACTIVE OXYGEN METABOLITE; RETINOID X RECEPTOR; RETINOL; RHO KINASE; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

CELL DIFFERENTIATION; CELL RENEWAL; CELL SURVIVAL; EMBRYONIC STEM CELL; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL RESEARCH; TOTIPOTENT STEM CELL; WNT SIGNALING PATHWAY;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; STEM CELL RESEARCH;

ANIMALIA;

EID: 84872568056     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920113804805340     Document Type: Review

References (106)

1. Citron, M. Alzheimer's disease: strategies for disease modification. Nat. Rev. Drug Discov., 2010, 9, 387-398
2. Obeso, J.A.; Rodriguez-Oroz, M.C.; Goetz, C.G.; Marin, C.; Kordower, J.H.; Rodriguez, M.; Hirsch, E.C.; Farrer, M.; Schapira, A.H.; Halliday, G. Missing pieces in the Parkinson's disease puzzle. Nat. Med., 2010, 16, 653-661.
3. Arenas, E. Towards stem cell replacement therapies for Parkinson's disease. Biochem. Biophys. Res. Commun., 2010, 1, 152-156.
4. Orlacchio, A.; Bernardi, G.; Orlacchio, A.; Martino, S. Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases. Curr. Med. Chem., 2010, 17, 595-608.
5. Aleckovic, M.; Simon, C. Is teratoma formation in stem cell research a characterization tool or a window to developmental biology? Reprod. Biomed. Online, 2008, 17, 270-280.
6. Beattie, G.M.; Lopez, A.D.; Bucay, N.; Hinton, A.; Firpo, M.T.; King, C.C.; Hayek, A. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells, 2005, 23, 489-495.
7. Levenstein, M.E.; Ludwig, T.E.; Xu, R.H.; Llanas, R.A.; VanDen-Heuvel-Kramer, K.; Manning, D.; Thomson, J.A. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells, 2006, 24, 568-574.
8. Xiao, L.; Yuan, X.; Sharkis, S.J. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells, 2006, 24, 1476-1486.
9. Greber, B.; Lehrach, H.; Adjaye, J. Fibroblast growth factor 2 modulates transforming growth factor β signaling in mouse embryonic fibroblasts and human ESCs (hESCs) to support hESC selfrenewal. Stem Cells, 2007, 25, 455-464.
10. Niwa, H.; Burdon, T.; Chambers, I.; Smith, A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev., 1998, 12, 2048-2060.
11. Ying, Q.L.; Nichols, J.; Chambers, I.; Smith, A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell, 2003, 115, 281-292.
12. Kiselyov, A.S.; Tkachenko, S.E.; Balakin, K.V.; Ivachtchenko, A.V. Small-molecule modulators of Hh and Wnt signaling pathways. Expert. Opin. Ther. Targets, 2007, 11, 1087-1101.
13. Jessen, J.R. Noncanonical Wnt signaling in tumor progression and metastasis. Zebrafish., 2009, 6, 21-28.
14. Takahashi-Yanaga, F.; Sasaguri, T. Drug development targeting the glycogen synthase kinase-3β (GSK-3β)-mediated signal transduction pathway: inhibitors of the Wnt/β-catenin signaling pathway as novel anticancer drugs. J. Pharmacol. Sci., 2009, 109, 179-183.
15. MacDonald, B.T.; Tamai, K.; He, X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev. Cell, 2009, 17, 9-26.
16. Forde, J.E.; Dale, T.C. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol. Life Sci., 2007, 64, 1930-1944.
17. Phukan, S.; Babu, V.S.; Kannoji, A.; Hariharan, R.; Balaji, V.N. GSK3β: role in therapeutic landscape and development of modulators. Br. J. Pharmacol., 2010, 160, 1-19.
18. Sato, N.; Meijer, L.; Skaltsounis, L.; Greengard, P.; Brivanlou, A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med., 2004, 10, 55-63.
19. Ying, Q.L.; Wray, J.; Nichols, J.; Batlle-Morera, L.; Doble, B.; Woodgett, J.; Cohen, P.; Smith, A. The ground state of embryonic stem cell self-renewal. Nature, 2008, 453, 519-523.
20. Bone, H.K.; Damiano, T.; Bartlett, S.; Perry, A.; Letchford, J.; Ripoll, Y.S.; Nelson, A.S.; Welham, M.J. Involvement of GSK-3 in regulation of murine embryonic stem cell self-renewal revealed by a series of bisindolylmaleimides. Chem. Biol., 2009, 16, 15-27.
21. Xu, R.H.; Chen, X.; Li, D.S.; Li, R.; Addicks, G.C.; Glennon, C.; Zwaka, T.P.; Thomson, J.A. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotechnol., 2002, 20, 1261-1264.
22. Duval, D.; Malaise, M.; Reinhardt, B.; Kedinger, C.; Boeuf, H. A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells. Cell Death. Differ., 2004, 11, 331-341
23. Qi, X.; Li, T.G.; Hao, J.; Hu, J.; Wang, J.; Simmons, H.; Miura, S.; Mishina, Y.; Zhao, G.Q. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc. Natl. Acad. Sci. USA, 2004, 101, 6027-6032.
24. Graichen, R.; Xu, X.; Braam, S.R.; Balakrishnan, T.; Norfiza, S.; Sieh, S.; Soo, S.Y.; Tham, S.C.; Mummery, C.; Colman, A.; Zweigerdt, R.; Davidson, B.P. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation, 2008, 76, 357-370.
25. Chen, S.; Do, J.T.; Zhang, Q.; Yao, S.; Yan, F.; Peters, E.C.; Scholer, H.R.; Schultz, P.G.; Ding, S. Self-renewal of embryonic stem cells by a small molecule. Proc. Natl. Acad. Sci. USA, 2006, 103, 17266-17271.
26. McLean, A.B.; D'Amour, K.A.; Jones, K.L.; Krishnamoorthy, M.; Kulik, M.J.; Reynolds, D.M.; Sheppard, A.M.; Liu, H.; Xu, Y.; Baetge, E.E.; Dalton, S. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells, 2007, 25, 29-38.
27. Xu, Y.; Zhu, X.; Hahm, H.S.; Wei, W.; Hao, E.; Hayek, A. Ding, S. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc. Natl. Acad. Sci. USA, 2010, 107, 8129-8134.
28. Watanabe, K.; Ueno, M.; Kamiya, D.; Nishiyama, A.; Matsumura, M.; Wataya, T.; Takahashi, J. B.; Nishikawa, S.; Nishikawa, S.; Muguruma, K. Sasai, Y. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol., 2007, 25, 681-686.
29. Krawetz, R.J.; Li, X.; Rancourt, D.E. Human embryonic stem cells: caught between a ROCK inhibitor and a hard place. Bioessays, 2009, 31, 336-343.
30. Andrews, P.D.; Becroft, M.; Aspegren, A.; Gilmour, J.; James, M.J.; McRae, S.; Kime, R.; Allcock, R.W.; Abraham, A.; Jiang, Z.; Strehl, R.; Mountford, J.C.; Milligan, G.; Houslay, M.D.; Adams, D.R. Frearson, J.A. High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules. Biochem. J., 2010, 432, 21-33.
31. Barbaric, I.; Gokhale, P.J.; Jones, M.; Glen, A.; Baker, D. Andrews, P.W. Novel regulators of stem cell fates identified by a multivariate phenotype screen of small compounds on human embryonic stem cell colonies. Stem Cell Res., 2010, 5, 104-119.
32. Germain, P.; Chambon, P.; Eichele, G.; Evans, R.M.; Lazar, M.A.; Leid, M.; De Lera, A.R.; Lotan, R.; Mangelsdorf, D.J.; Gronemeyer, H. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol. Rev., 2006, 58, 760-772.
33. Germain, P.; Chambon, P.; Eichele, G.; Evans, R.M.; Lazar, M.A.; Leid, M.; De Lera, A.R.; Lotan, R.; Mangelsdorf, D.J.; Gronemeyer, H. International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol. Rev., 2006, 58, 712-725.
34. Chen, L.; Yang, M.; Dawes, J.; Khillan, J.S. Suppression of ES cell differentiation by retinol (vitamin A) via the overexpression of Nanog. Differentiation, 2007, 75, 682-693.
35. Chen, L.; Khillan, J.S. Promotion of feeder-independent selfrenewal of embryonic stem cells by retinol (vitamin A). Stem Cells, 2008, 26, 1858-1864.
36. Li, X.J.; Hu, B.Y.; Jones, S.A.; Zhang, Y.S.; Lavaute, T.; Du, Z.W.; Zhang, S.C. Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells, 2008, 26, 886-893.
37. Cajanek, L.; Ribeiro, D.; Liste, I.; Parish, C.L.; Bryja, V.; Arenas, E. Wnt/β-catenin signaling blockade promotes neuronal induction and dopaminergic differentiation in embryonic stem cells. stem cells, 2009, 27, 2917-2927.
38. Osakada, F.; Jin, Z.B.; Hirami, Y.; Ikeda, H.; Danjyo, T.; Watanabe, K.; Sasai, Y.; Takahashi, M. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J. Cell Sci., 2009, 122, 3169-3179.
39. Borowiak, M.; Maehr, R.; Chen, S.; Chen, A.E.; Tang, W.; Fox, J.L.; Schreiber, S.L.; Melton, D.A. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell, 2009, 4, 348-358.
40. Zhu, S.; Wurdak, H.; Wang, J.; Lyssiotis, C.A.; Peters, E.C.; Cho, C.Y.; Wu, X.; Schultz, P.G. A small molecule primes embryonic stem cells for differentiation. Cell Stem Cell, 2009, 4, 416-426.
41. Mae, S.; Shirasawa, S.; Yoshie, S.; Sato, F.; Kanoh, Y.; Ichikawa, H.; Yokoyama, T.; Yue, F.; Tomotsune, D.; Sasaki, K. Combination of small molecules enhances differentiation of mouse embryonic stem cells into intermediate mesoderm through BMP7-positive cells. Biochem. Biophys. Res. Commun., 2010, 393, 877-882.
42. Chambers, S.M.; Fasano, C.A.; Papapetrou, E.P.; Tomishima, M.; Sadelain, M.; Studer, L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol., 2009, 27, 275-280.
43. Mahmood, A.; Harkness, L.; Schroder, H.D.; Abdallah, B.M.; Kassem, M. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-β/Activin/Nodal signaling using SB-431542. J. Bone Miner. Res., 2010, 25, 1216-1233.
44. Zhou, J.; Su, P.; Li, D.; Tsang, S.; Duan, E.; Wang, F. Highefficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor β superfamily receptors. Stem Cells, 2010, 28, 1741-1750.
45. Morizane, A.; Doi, D.; Kikuchi, T.; Nishimura, K.; Takahashi, J. Small-molecule inhibitors of bone morphogenic protein and activin/ nodal signals promote highly efficient neural induction from human pluripotent stem cells. J. Neurosci. Res., 2011, 89, 117-126.
46. Wada, T.; Honda, M.; Minami, I.; Tooi, N.; Amagai, Y.; Nakatsuji, N.; Aiba, K. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS. One., 2009, 4, e6722.
47. Hao, J.; Daleo, M.A.; Murphy, C.K.; Yu, P.B.; Ho, J.N.; Hu, J.; Peterson, R.T.; Hatzopoulos, A.K.; Hong, C.C. Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS. One, 2008, 3, e2904.
48. Gaines, K.K. Phenazopyridine hydrochloride: the use and abuse of an old standby for UTI. Urol. Nurs., 2004, 24, 207-209.
49. Suter, D.M.; Preynat-Seauve, O.; Tirefort, D.; Feki, A.; Krause, K.H. Phenazopyridine induces and synchronizes neuronal differentiation of embryonic stem cells. J. Cell Mol. Med., 2009, 13, 3517-3527.
50. Wu, X.; Walker, J.; Zhang, J.; Ding, S.; Schultz, P.G. Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway. Chem. Biol., 2004, 11, 1229-1238.
51. Schneider, J.W.; Gao, Z.; Li, S.; Farooqi, M.; Tang, T.S.; Bezprozvanny, I.; Frantz, D.E.; Hsieh, J. Small-molecule activation of neuronal cell fate. Nat. Chem. Biol., 2008, 4, 408-410.
52. Kim, N.R.; Kang, S.K.; Ahn, H.H.; Kwon, S.W.; Park, W.S.; Kim, K.S.; Kim, S.S.; Jung, H.J.; Choi, S.U.; Ahn, J.H.; Kim, K.R. Discovery of a new and efficient small molecule for neuronal differentiation from mesenchymal stem cell. J. Med. Chem., 2009, 52, 7931-7933.
53. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126, 663-676.
54. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131, 861-872.
55. Lowry, W.E.; Richter, L.; Yachechko, R.; Pyle, A.D.; Tchieu, J.; Sridharan, R.; Clark, A.T.; Plath, K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA, 2008, 105, 2883-2888.
56. Park, I.H.; Zhao, R.; West, J.A.; Yabuuchi, A.; Huo, H.; Ince, T.A.; Lerou, P.H.; Lensch, M.W.; Daley, G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 2008, 451, 141-146.
57. Marion, R.M.; Strati, K.; Li, H.; Tejera, A.; Schoeftner, S.; Ortega, S.; Serrano, M.; Blasco, M.A. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell, 2009, 4, 141-154.
58. Chin, M.H.; Mason, M.J.; Xie, W.; Volinia, S.; Singer, M.; Peterson, C.; Ambartsumyan, G.; Aimiuwu, O.; Richter, L.; Zhang, J.; Khvorostov, I.; Ott, V.; Grunstein, M.; Lavon, N.; Benvenisty, N.; Croce, C.M.; Clark, A.T.; Baxter, T.; Pyle, A.D.; Teitell, M.A.; Pelegrini, M.; Plath, K.; Lowry, W.E. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 2009, 5, 111-123.
59. Guenther, M.G.; Frampton, G.M.; Soldner, F.; Hockemeyer, D.; Mitalipova, M.; Jaenisch, R. Young, R.A. Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell, 2010, 7, 249-257.
60. Chin, M.H.; Pellegrini, M.; Plath, K.; Lowry, W.E. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell, 2010, 7, 263-269.
61. Park, I.H.; Arora, N.; Huo, H.; Maherali, N.; Ahfeldt, T.; Shimamura, A.; Lensch, M.W.; Cowan, C.; Hochedlinger, K.; Daley, G.Q. Disease-specific induced pluripotent stem cells. Cell, 2008, 134, 877-886.
62. Sun, N.; Panetta, N.J.; Gupta, D.M.; Wilson, K.D.; Lee, A.; Jia, F.; Hu, S.; Cherry, A.M.; Robbins, R.C.; Longaker, M.T.; Wu, J.C. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl. Acad. Sci. USA, 2009, 106, 15720-15725.
63. Utikal, J.; Maherali, N.; Kulalert, W.; Hochedlinger, K. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J. Cell Sci., 2009, 122, 3502-3510.
64. Loh, Y.H.; Agarwal, S.; Park, I.H.; Urbach, A.; Huo, H.; Heffner, G.C.; Kim, K.; Miller, J.D.; Ng, K.; Daley, G.Q. Generation of induced pluripotent stem cells from human blood. Blood, 2009, 113, 5476-5479.
65. Aasen, T.; Raya, A.; Barrero, M.J.; Garreta, E.; Consiglio, A.; Gonzalez, F.; Vassena, R.; Bilic, J.; Pekarik, V.; Tiscornia, G.; Edel, M.; Boue, S.; Izpisua Belmonte, J.C. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol., 2008, 26, 1276-1284.
66. Soldner, F.; Hockemeyer, D.; Beard, C.; Gao, Q.; Bell, G.W.; Cook, E.G.; Hargus, G.; Blak, A.; Cooper, O.; Mitalipova, M.; Isacson, O.; Jaenisch, R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 2009, 136, 964-977.
67. Ebert, A.D.; Yu, J.; Rose, F.F. Jr.; Mattis, V.B.; Lorson, C.L.; Thomson, J.A.; Svendsen, C.N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 2009, 457, 277-280.
68. Palma, I.; Pena, R.Y.; Contreras, A.; Ceballos-Reyes, G.; Coyote, N.; Erana, L.; Kofman-Alfaro, S.; Queipo, G. Participation of OCT3/4 and β-catenin during dysgenetic gonadal malignant transformation. Cancer Lett., 2008, 263, 204-211.
69. Wei, D.; Kanai, M.; Huang, S.; Xie, K. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis, 2006, 27, 23-31.
70. Chen, Y.; Shi, L.; Zhang, L.; Li, R.; Liang, J.; Yu, W.; Sun, L.; Yang, X.; Wang, Y.; Zhang, Y.; Shang, Y. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J. Biol. Chem., 2008, 283, 17969-17978.
71. Chiou, S.H.; Yu, C.C.; Huang, C.Y.; Lin, S.C.; Liu, C.J.; Tsai, T.H.; Chou, S.H.; Chien, C.S.; Ku, H.H.; Lo, J.F. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and highgrade oral squamous cell carcinoma. Clin. Cancer Res., 2008, 14, 4085-4095.
72. Zhou, H.; Wu, S.; Joo, J.Y.; Zhu, S.; Han, D.W.; Lin, T.; Trauger, S.; Bien, G.; Yao, S.; Zhu, Y.; Siuzdak, G.; Scholer, H.R.; Duan, L.; Ding, S. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 2009, 4, 381-384.
73. Gonzalez, F.; Barragan, M.M.; Tiscornia, G.; Montserrat, P.N.; Vassena, R.; Batlle, M.L.; Rodriguez, P. I.; Izpisua Belmonte, J.C. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc. Natl. Acad. Sci. USA, 2009, 106, 8918-8922.
74. Carey, B.W.; Markoulaki, S.; Beard, C.; Hanna, J.; Jaenisch, R. Single-gene transgenic mouse strains for reprogramming adult somatic cells. Nat. Methods, 2010, 7, 56-59.
75. Yu, J.; Hu, K.; Smuga-Otto, K.; Tian, S.; Stewart, R.; Slukvin, I.I.; Thomson, J.A. Human induced pluripotent stem cells free of vector and transgene sequences. Science, 2009, 324, 797-801.
76. Kaji, K.; Norrby, K.; Paca, A.; Mileikovsky, M.; Mohseni, P.; Woltjen, K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 2009, 458, 771-775.
77. Woltjen, K.; Michael, I.P.; Mohseni, P.; Desai, R.; Mileikovsky, M.; Hamalainen, R.; Cowling, R.; Wang, W.; Liu, P.; Gertsenstein, M.; Kaji, K.; Sung, H.K.; Nagy, A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 2009, 458, 766-770.
78. Yusa, K.; Rad, R.; Takeda, J.; Bradley, A. Generation of transgenefree induced pluripotent mouse stem cells by the piggyBac transposon. Nat. Methods, 2009, 6, 363-369.
79. Warren, L.; Manos, P.D.; Ahfeldt, T.; Loh, Y.H.; Li, H.; Lau, F.; Ebina, W.; Mandal, P.K.; Smith, Z.D.; Meissner, A.; Daley, G.Q.; Brack, A.S.; Collins, J.J.; Cowan, C.; Schlaeger, T.M.; Rossi, D.J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 2010, 7, 618-630.
80. Masui, S.; Nakatake, Y.; Toyooka, Y.; Shimosato, D.; Yagi, R.; Takahashi, K.; Okochi, H.; Okuda, A.; Matoba, R.; Sharov, A.A.; Ko, M.S.; Niwa, H. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol., 2007, 9, 625-635.
81. Kim, J.B.; Zaehres, H.; Wu, G.; Gentile, L.; Ko, K.; Sebastiano, V.; Arauzo-Bravo, M.J.; Ruau, D.; Han, D.W.; Zenke, M.; Scholer, H.R. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature, 2008, 454, 646-650.
82. Duinsbergen, D.; Eriksson, M.; 't Hoen, P.A.; Frisen, J.; Mikkers, H. Induced pluripotency with endogenous and inducible genes. Exp. Cell Res., 2008, 314, 3255-3263.
83. Silva, J.; Barrandon, O.; Nichols, J.; Kawaguchi, J.; Theunissen, T.W.; Smith, A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS. Biol., 2008, 6, e253.
84. Kim, J.B.; Sebastiano, V.; Wu, G.; Arauzo-Bravo, M.J.; Sasse, P.; Gentile, L.; Ko, K.; Ruau, D.; Ehrich, M.; van den, B.D.; Meyer, J.; Hubner, K.; Bernemann, C.; Ortmeier, C.; Zenke, M.; Fleischmann, B.K.; Zaehres, H.; Scholer, H.R. Oct4-induced pluripotency in adult neural stem cells. Cell, 2009, 136, 411-419.
85. Shi, Y.; Do, J.T.; Desponts, C.; Hahm, H.S.; Scholer, H.R.; Ding, S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell, 2008, 2, 525-528.
86. Kubicek, S.; O'Sullivan, R.J.; August, E.M.; Hickey, E.R.; Zhang, Q.; Teodoro, M.L.; Rea, S.; Mechtler, K.; Kowalski, J.A.; Homon, C.A.; Kelly, T.A.; Jenuwein, T. Reversal of H3K9me2 by a smallmolecule inhibitor for the G9a histone methyltransferase. Mol. Cell, 2007, 25, 473-481.
87. Shi, Y.; Desponts, C.; Do, J.T.; Hahm, H.S.; Scholer, H.R.; Ding, S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell, 2008, 3, 568-574.
88. Huangfu, D.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Snitow, M.; Chen, A.E.; Melton, D.A. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol., 2008, 26, 795-797.
89. Huangfu, D.; Osafune, K.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Chen, S.; Muhlestein, W.; Melton, D.A. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol., 2008, 26, 1269-1275.
90. Lyssiotis, C.A.; Foreman, R.K.; Staerk, J.; Garcia, M.; Mathur, D.; Markoulaki, S.; Hanna, J.; Lairson, L.L.; Charette, B.D.; Bouchez, L.C.; Bollong, M.; Kunick, C.; Brinker, A.; Cho, C.Y.; Schultz, P.G.; Jaenisch, R. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc. Natl. Acad. Sci. USA, 2009, 106, 8912-8917.
91. Li, W.; Wei, W.; Zhu, S.; Zhu, J.; Shi, Y.; Lin, T.; Hao, E.; Hayek, A.; Deng, H.; Ding, S. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell, 2009, 4, 16-19.
92. Meissner, A.; Wernig, M.; Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol., 2007, 25, 1177-1181.
93. Mikkelsen, T.S.; Hanna, J.; Zhang, X.; Ku, M.; Wernig, M.; Schorderet, P.; Bernstein, B.E.; Jaenisch, R.; Lander, E.S.; Meissner, A. Dissecting direct reprogramming through integrative genomic analysis. Nature, 2008, 454, 49-55.
94. Esteban, M.A.; Wang, T.; Qin, B.; Yang, J.; Qin, D.; Cai, J.; Li, W.; Weng, Z.; Chen, J.; Ni, S.; Chen, K.; Li, Y.; Liu, X.; Xu, J.; Zhang, S.; Li, F.; He, W.; Labuda, K.; Song, Y.; Peterbauer, A.; Wolbank, S.; Redl, H.; Zhong, M.; Cai, D.; Zeng, L.; Pei, D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell, 2010, 6, 71-79.
95. Zhou, J.; Su, P.; Li, D.; Tsang, S.; Duan, E. Wang, F. Highefficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor β superfamily receptors. Stem Cells, 2010, 28, 1741-1750.
96. Dimos, J.T.; Rodolfa, K.T.; Niakan, K.K.; Weisenthal, L.M.; Mitsumoto, H.; Chung, W.; Croft, G.F.; Saphier, G.; Leibel, R.; Goland, R.; Wichterle, H.; Henderson, C.E.; Eggan, K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 2008, 321, 1218-1221.
97. Chamberlain, S.J.; Chen, P.F.; Ng, K.Y.; Bourgois-Rocha, F.; Lemtiri-Chlieh, F.; Levine, E.S.; Lalande, M. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc. Natl. Acad. Sci. USA, 2010, 107, 17668-17673.
98. Carvajal-Vergara, X.; Sevilla, A.; D'Souza, S.L.; Ang, Y.S.; Schaniel, C.; Lee, D.F.; Yang, L.; Kaplan, A.D.; Adler, E.D.; Rozov, R.; Ge, Y.; Cohen, N.; Edelmann, L.J.; Chang, B.; Waghray, A.; Su, J.; Pardo, S.; Lichtenbelt, K.D.; Tartaglia, M.; Gelb, B.D.; Lemischka, I.R. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature, 2010, 465, 808-812.
99. Amariglio, N.; Hirshberg, A.; Scheithauer, B.W.; Cohen, Y.; Loewenthal, R.; Trakhtenbrot, L.; Paz, N.; Koren-Michowitz, M.; Waldman, D.; Leider-Trejo, L.; Toren, A.; Constantini, S.; Rechavi, G. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS. Med., 2009, 6, e1000029-
100. Raya, A.; Rodriguez-Piza, I.; Guenechea, G.; Vassena, R.; Navarro, S.; Barrero, M.J.; Consiglio, A.; Castella, M.; Rio, P.; Sleep, E.; Gonzalez, F.; Tiscornia, G.; Garreta, E.; Aasen, T.; Veiga, A.; Verma, I.M.; Surralles, J.; Bueren, J.; Izpisua Belmonte, J.C. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature, 2009, 460, 53-59.
101. Hacein-Bey-Abina, S.; Garrigue, A.; Wang, G.P.; Soulier, J.; Lim, A.; Morillon, E.; Clappier, E.; Caccavelli, L.; Delabesse, E.; Beldjord, K.; Asnafi, V.; MacIntyre, E.; Dal Cortivo, L.; Radford, I.; Brousse, N.; Sigaux, F.; Moshous, D.; Hauer, J.; Borkhardt, A.; Belohradsky, B.H.; Wintergerst, U.; Velez, M.C.; Leiva, L.; Sorensen, R.; Wulffraat, N.; Blanche, S.; Bushman, F.D.; Fischer, A.; Cavazzana-Calvo, M. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest., 2008, 118, 3132-3142.
102. Wernig, M.; Zhao, J.P.; Pruszak, J.; Hedlund, E.; Fu, D.; Soldner, F.; Broccoli, V.; Constantine-Paton, M.; Isacson, O.; Jaenisch, R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA, 2008, 105, 5856-5861.
103. Knoepfler, P.S. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells, 2009, 27, 1050-1056.
104. Shih, C.C.; Forman, S.J.; Chu, P.; Slovak, M. Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice. Stem Cells Dev., 2007, 16, 893-902.
105. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germlinecompetent induced pluripotent stem cells. Nature, 2007, 448, 313-317.
106. Kochegarov, A. Small molecules for stem cells. Expert. Opin. Ther. Pat, 2009, 19, 275-281.